Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity - USD ($) $ in Thousands	Total	Redeemable Convertible Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income	Accumulated Deficit
Balance at Dec. 31, 2020	$ (221,811)		$ 1	$ 6,269	$ 11	$ (228,092)
Temporary Equity, Balance, shares at Dec. 31, 2020		12,397,838
Temporary Equity, Balance at Dec. 31, 2020		$ 123,255
Balance, shares at Dec. 31, 2020			1,192,299
Conversion of Series D redeemable convertible preferred stock warrants into common stock warrants upon initial public offering	370			370
Conversion of Series D redeemable convertible preferred stock into common stock upon initial public offering, shares		(12,397,838)	12,397,838
Conversion of Series D redeemable convertible preferred stock into common stock upon initial public offering	123,255	$ (123,255)	$ 12	123,243
Conversion of 2018, 2019 and 2020 Notes into common stock upon initial public offering	89,303		$ 7	89,296
Conversion of 2018, 2019 and 2020 Notes into common stock upon initial public offering, shares			7,006,228
Issuance of common stock upon initial public offering, net of issuance costs and underwriting discount of $8,414	66,585		$ 6	66,579
Issuance of common stock upon initial public offering, net of issuance costs and underwriting discount of $8,414, shares			6,250,000
Issuance of common stock upon exercise of stock options	975		$ 2	973
Issuance of common stock upon exercise of stock options, shares			1,612,363
Issuance of common stock upon early exercise of stock options, shares			363,555
Vesting of early exercised stock options	74			74
Stock-based compensation expense	6,817			6,817
Net loss	(21,464)					(21,464)
Balance at Dec. 31, 2021	44,104		$ 28	293,621	11	(249,556)
Balance, shares at Dec. 31, 2021			28,822,283
Issuance of common stock upon release of RSUs	1		$ 1
Issuance of common stock upon release of RSUs, shares			535,122
Issuance of common stock upon exercise of stock options	$ 35			35
Issuance of common stock upon exercise of stock options, shares	57,654		57,654
Vesting of early exercised stock options	$ 175			175
ESPP purchase, shares			401,102
Stock-based compensation expense	6,978			6,978
Net loss	(34,112)					(34,112)
Balance at Dec. 31, 2022	$ 17,181		$ 29	$ 300,809	$ 11	$ (283,668)
Balance, shares at Dec. 31, 2022			29,816,161